News
1d
Life Insurance International on MSNGIC and IRDAI push for independent healthcare regulator – reportThe proposed regulator would mirror existing sectoral authorities such as IRDAI for insurance, SEBI for capital markets, and ...
Brazil is experiencing a regulatory revolution that is fundamentally transforming its medical device clinical trial landscape ...
A new study by investigators from Europe, including the Netherlands and the United Kingdom (UK), has shed light on ...
In this week’s edition of InnovationRx, we look at the health impact of the Republican spending bill, a startup that built a hospital in India to test its AI software, the impact of the vaccine panel ...
A new study by investigators from Europe, including the Netherlands and the United Kingdom (UK), has shed light on ...
Transcriptional regulatory elements are nucleotide sequences of a gene that are involved in regulation of genetic transcription. These include the promoter, plus response elements, activator and ...
The results of technology research and development must find their way into the published literature. New models of regulation could help.
Approximately 50% of people with neurofibromatosis type 1 (NF1), one of the most common monogenetic conditions in humans,1 will develop plexiform neurofibromas (PNF), benign but complex nerve sheath ...
The FDA has stopped new clinical trials that export American citizens’ living cells from the U.S. to “China and other hostile countries for genetic engineering and subsequent infusion” back ...
Despite initiatives such as Accelerating Clinical Trials in the EU (ACT EU), sponsors still face an administrative burden and site contract problems when it comes to initiating trials. Experts advised ...
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, ...
These trials are actively recruiting patients at leading cancer centers worldwide, expanding access to novel treatments for people facing cancer. As research progresses, these developments may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results